MEDICINOS SPRENDIMAI, UAB - financials and debts

Company age: 17 y. 2 mo.

Update

MEDICINOS SPRENDIMAI - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 314,244 357,380 435,540 461,039 448,687 479,654 506,142 450,984
Profit before tax - - - - - - - -
Net profit 17,038 42,121 56,086 30,888 31,056 42,862 50,122 9,456
Equity 8,518 15,757 31,801 62,689 93,992 89,763 143,657 101,542
Liabilities 86,641 78,760 95,073 84,389 55,132 62,761 49,753 57,832
Non-current assets 38,319 22,522 44,406 97,471 88,217 56,878 36,676 17,544
Current assets 55,457 71,056 81,527 48,749 60,169 94,957 156,068 141,830
Total assets 93,776 93,578 125,933 146,220 148,386 151,835 192,744 159,374
Taxes paid
STI taxes - - - - - 60,998 75,629 79,068
Social insurance contributions - - - - - 57,039 64,511 63,720
Financial indicators
Revenue change y/y +2.2% +13.7% +21.9% +5.9% -2.7% +6.9% +5.5% -10.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 18.2% 45.0% 44.5% 21.1% 20.9% 28.2% 26.0% 5.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 200.0% 267.3% 176.4% 49.3% 33.0% 47.8% 34.9% 9.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 5.4% 11.8% 12.9% 6.7% 6.9% 8.9% 9.9% 2.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 10.2 5.0 3.0 1.3 0.6 0.7 0.3 0.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 20,165 21,443 26,132 31,434 31,860 36,429 38,934 38,111

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

MEDICINOS SPRENDIMAI - Social security debts

From To Debt, €
2023-02-06 2023-02-06 0.42
2023-01-24 2023-02-03 0.42
2022-07-25 2022-08-15 1.26

MEDICINOS SPRENDIMAI - VMI tax arrears

From To Overdue, €
2026-01-18 2026-02-27 3.25
2026-01-17 2026-01-17 919.55
2026-01-14 2026-01-16 920.3
2026-01-01 2026-01-13 468.05
2025-12-31 2025-12-31 369.4
2025-09-25 2025-09-29 5.28
2025-09-19 2025-09-24 2540.32
2025-08-13 2025-08-16 246.94
2025-07-16 2025-07-20 79.39
2025-04-16 2025-04-28 126.13
2025-03-27 2025-04-15 1.76
2025-03-25 2025-03-26 1091.15
2025-01-15 2025-01-15 3895.57

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
MEDICINOS SPRENDIMAI, UAB (code 302418510) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €451.0K and net profit of €9.5K, compared with €506.1K revenue and €50.1K net profit in 2024. This reflects a 10.9% year-on-year decline in revenue and a much weaker profitability profile, with the profit margin falling to 2.1% from 9.9% in 2024. Over the three-year period, revenue increased from €479.7K in 2023 to €506.1K in 2024 before easing in 2025, while net profit moved from €42.9K to €50.1K and then declined sharply. As of 2025, total assets stood at €159.4K, equity at €101.5K and liabilities at €57.8K. The equity ratio was 63.7% and debt-to-equity 0.57, indicating a relatively moderate leverage position. Asset turnover was 2.83x, ROE 9.3% and ROA 5.9%. Revenue per employee was €41.0K and profit per employee €860.